ArticlePloS one2020

The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer's disease, other types of dementia and non-demented controls: A cross-sectional study.

Ditte S Jonesco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.